Genetic variants at the ITPA locus protect against ribavirin-induced hemolytic anemia and dose reduction in an HCV G2/G3 cohort

European Journal of Gastroenterology & Hepatology
Arne Nørgaard EskesenOlav Dalgard

Abstract

Two functional genetic variants in the inosine triphosphatase (ITPA) gene have been shown to be strongly associated with protection from ribavirin (RBV)-induced hemolysis. We aimed at evaluating this finding in a chronic hepatitis C genotype 2/3 cohort with a predominance of genotype 3 patients where available data are scarce. A second objective was to determine whether a protective association translated into the need for RBV reduction and hence a possible impact on treatment response. Overall, 457 patients were recruited from two trials of genotype 2/3 patients treated with pegylated interferon α-2b and weight-based RBV. rs1127354 and rs7270101 were genotyped and a composite ITPAase deficiency variable was graded according to the two single nucleotide polymorphisms. The primary endpoints were hemoglobin (Hb) decline from baseline and Hb decline of more than 3 g/dl at week 4. Both single nucleotide polymorphisms and the composite ITPAase deficiency variable were strongly and independently associated with protection from a decline in Hb at week 4 in multivariate linear regression models (Prs1127354=7.0×10, Prs7270101=0.0036, PITPase deficiency variable =6.3×10). Patients with any degree of reduced ITPAase activity were less lik...Continue Reading

References

Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Oct 21, 1999·Scandinavian Journal of Infectious Diseases·J WestinR Wejstål
Mar 25, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L De FranceschiR Corrocher
Jul 14, 2001·Journal of Hepatology·H Van VlierberghUNKNOWN BASL Steering Committee
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Oct 18, 2002·Human Genetics·Satoshi SumiJohn A Duley
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jay H Hoofnagle
Aug 28, 2003·Scandinavian Journal of Gastroenterology·O DalgardH Bell
Jan 30, 2004·Therapeutic Drug Monitoring·Yorinobu MaedaMikihisa Takano
Mar 5, 2004·Annals of Internal Medicine·Stephanos J HadziyannisUNKNOWN PEGASYS International Study Group
Oct 16, 2004·Journal of Gastroenterology and Hepatology·Hideyuki NomuraHiromi Ishibashi
Nov 24, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Olav DalgardHelge Bell
Feb 17, 2007·Therapeutic Drug Monitoring·Srebrena AtanasovaNicolas von Ahsen
Nov 3, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Olav DalgardUNKNOWN North-C Group
Feb 25, 2009·Seminars in Liver Disease·Patrizia Burra
May 1, 2009·The New England Journal of Medicine·John G McHutchisonUNKNOWN PROVE1 Study Team
May 1, 2009·The New England Journal of Medicine·Christophe HézodeUNKNOWN PROVE2 Study Team
Apr 17, 2010·Nature Reviews. Genetics·Noah A RosenbergMichael Boehnke
Oct 28, 2010·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Naoya SakamotoMamoru Watanabe
Jan 29, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alexander J ThompsonAlessandra Mangia
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Amir MoghaddamOlav Dalgard

❮ Previous
Next ❯

Citations

Mar 25, 2014·World Journal of Gastroenterology : WJG·Nikolaos K GatselisGeorge N Dalekos
Feb 13, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Karolina RembeckMartin Lagging
Mar 25, 2014·Alimentary Pharmacology & Therapeutics·A F StättermayerP Ferenci
Oct 12, 2013·Pharmacotherapy·Marina Kawaguchi-Suzuki, Reginald F Frye
Jun 14, 2015·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Javier AmpueroManuel Romero-Gómez
Jun 19, 2013·Biochimie·Amanda D GallNicholas E Burgis
Oct 24, 2014·Future Microbiology·Jesper WaldenströmMartin Lagging
Jun 2, 2016·Pharmacogenomics·Antonio D'AvolioGiovanni Di Perri
Feb 7, 2013·The Annals of Pharmacotherapy·Lauren M Hynicka, Emily L Heil
Oct 25, 2016·Journal of Biomedical Science·Nicholas E Burgis
Jun 26, 2015·Pharmacogenetics and Genomics·Scott R ShuldinerTeri E Klein
Sep 19, 2015·World Journal of Clinical Cases·Nicola CoppolaEvangelista Sagnelli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.